Xiamen Amoytop Biotech Co., Ltd. (688278.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
2423
First IPO Date
January 17, 2020
| Name | Title | Pay | Year Born |
| Liyu Shi | Deputy General Manager | 0 | 1980 |
| Yiling Yang | Chief Financial Officer, Accounting Supervisor, Deputy GM & Secretary | 0 | 1975 |
| Liping Lai | Vice President & Director | 0 | 1971 |
| Linzhong Zhang | Deputy General Manager | 0 | 1969 |
| Meihua Yang | Deputy General Manager | 0 | 1972 |
| Jiehua Zheng | Deputy General Manager | 0 | 1980 |
| Weidong Zhou | Deputy General Manager | 0 | 1971 |
| Li Sun | Chairman & GM | 0 | 1966 |
Xiamen Amoytop Biotech Co., Ltd. specializes in the creation, commercialization, and distribution of biopharmaceutical products within China, utilizing advanced genetic engineering techniques. Its offerings span a variety of pharmaceutical goods, including finished drug formulations, diagnostic reagents, and active pharmaceutical ingredients (APIs). The company further extends its services to include bespoke contract manufacturing. Founded in 1996, the firm is headquartered in Xiamen, China.